Showing results (421-430 of 541) with videos related to
Sort By:
Pageof 55
Clinical and Molecular Hepatology|February 14, 2017
Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patientsGoh Eun Chung, Eun Ju Cho, Jeong-Hoon Lee, et al.Hepatology Communications|January 8, 2020
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis BAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.Antiviral Therapy|April 29, 2022
Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4+ cell countsGérard M Kouamé, Delphine Gabillard, Raoul Moh, et al.Development (Cambridge, England)|July 13, 2007
The TFIID subunit TAF4 regulates keratinocyte proliferation and has cell-autonomous and non-cell-autonomous tumour suppressor activity in mouse epidermisAnas Fadloun, Dominique Kobi, Jean-Christophe Pointud, et al.Journal of Hepatology|August 16, 2022
Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertensionElisabetta Degasperi, Maria Paola Anolli, Sara Colonia Uceda Renteria, et al.Journal of Hepatology|November 19, 2013
N-glycosylation mutations within hepatitis B virus surface major hydrophilic region contribute mostly to immune escapeDe-Min Yu, Xin-Hua Li, Vannary Mom, et al.Nature Structural & Molecular Biology|March 9, 2004
Regulation of the p300 HAT domain via a novel activation loopPaul R Thompson, Dongxia Wang, Ling Wang, et al.JHEP Reports : Innovation in Hepatology|July 8, 2024
Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosisHyunjae Shin, Won-Mook Choi, Seung Up Kim, et al.Journal of Viral Hepatitis|July 5, 2022
Significance of serum HBV RNA in non-cirrhotic HBeAg-negative chronic hepatitis B patients who discontinue effective antiviral therapyMargarita Papatheodoridi, Eleni Papachristou, Zissis Moschidis, et al.JHEP Reports : Innovation in Hepatology|February 10, 2022
Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitroMaud Michelet, Dulce Alfaiate, Brieux Chardès, et al.Pageof 55